Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential
Medical Research Archives · 07.07.2026 · 14 (6)
DOI: 10.18103/mra.2026.0326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 07.07.2026. Verfasst von Youcef M Rustum und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
TGF-?1, a multifunctional cytokine ubiquitously overexpressed in advanced cancers, is a critical target implicated in drug resistance, immune evasion, increased tumor angiogenesis, and unstable TME. We discovered for the first time that pharmacologic doses of SLM and AA are potent in vivo selective inhibitors of TGF-?1. Inhibition of TGF-?1 was associated with time-dependent inhibition of HIFs, PD-L1, VEGF, CAR-T cell activation, activation of TET by AA, inhibition of DNMTs by SLM, stabilization of tumor vasculature, increased drug delivery to tumor cells, and enhanced efficacy of oncolytic agents. The pleiotropic effects induced by pharmacologic doses and schedule of SLM offer the potential for enhancing the therapeutic efficacy of immunotherapy in cancer patients.
Zitieren
APA
Rustum, Y. M., Rataan, A. O., Zakharia, Y., Davila, M., Amissah, O. B., & Kim, G. B. (2026). Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential. Medical Research Archives, 14(6). https://doi.org/10.18103/mra.2026.0326
Vancouver
Rustum YM, Rataan AO, Zakharia Y, Davila M, Amissah OB, Kim GB. Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential. Medical Research Archives. 2026;14(6). doi:10.18103/mra.2026.0326
BibTeX
@article{Rustum2026,
author = {Rustum, Youcef M and Rataan, Aseel O. and Zakharia, Yousef and Davila, Marco and Amissah, Obed B. and Kim, Gloria B.},
title = {Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential},
journal = {Medical Research Archives},
year = {2026},
volume = {14},
number = {6},
doi = {10.18103/mra.2026.0326}
}
EUVIMED